Pharmacological Targeting Of Arylamine N-Acetyltransferase I
Funder
National Health and Medical Research Council
Funding Amount
$474,653.00
Summary
This project will investigate a novel approach to controlling how cancer cells grow and spread. It plans to study whether a protein termed N-acetyltransferase is a key to determining whether cancer cells can change thier characteristics, allowing them to invade other tissues. In addition, novel approaches to target this protein are proposed. If successful, the work outlined in this project will open new avenues to understanding and trerating cancers.
Environmental Regulation Of Virulence In Attaching And Effacing Enterobacteria
Funder
National Health and Medical Research Council
Funding Amount
$569,063.00
Summary
Disease-causing bacteria must respond to the extreme conditions, such as acid and bile, which they encounter in their hosts. They achieve this by sensing their environment and activating genes that enhance their survival and ability to cause disease. In this project we will define the mechanisms by which these sensing and response pathways occur, using E. coli as a model. The information obtained from this research should lead to new strategies to treat and prevent bacterial infections.
Novel Methods To Diagnose Clinical Egg Allergy And Predict Prognostic Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Australia has the highest rate of food allergy in the world. Despite ongoing research into the area, there is currently no cure, with patient avoidance the most effective way to prevent food reactions. A food challenge is the gold standard for food allergy diagnosis. Although definitive, it is associated with a risk of anaphylaxis. My research aims to identify the biological differences between having food allergy and not having food allergy to develop novel diagnostic methods.
Post-GWAS Functional Characterisation Of Breast Cancer Susceptibility Loci
Funder
National Health and Medical Research Council
Funding Amount
$764,632.00
Summary
Recent studies have identified regions within the human genome in which DNA sequence variations are associated with an increased risk of breast cancer. Several of these regions do not contain any known genes, suggesting that regulatory DNA sequences are responsible for the associated risk. The aim of this proposal is to identify and characterise these DNA sequences. Understanding how sequences variations in these regions contribute to breast cancer will provide novel avenues for therapy.
Genomic Characterisation Of Asbestos Related Lung Cancer
Funder
National Health and Medical Research Council
Funding Amount
$88,099.00
Summary
Lung cancer causes more deaths in Australia than any other cancer. Smoking is the main cause, but people exposed to asbestos are also at risk, and it can be difficult to know whether a case is due to tobacco, asbestos or both. We will study lung cancer genes in people with asbestos exposure to find whether asbestos lung cancer has a specific pattern of abnormal genes (signature). If so, this could help people entitled to compensation, and also point to new treatments for asbestos lung cancer
Retrotransposon Regulation Of The Human Innate Immune Response
Funder
National Health and Medical Research Council
Funding Amount
$231,937.00
Summary
Complete sequencing of the human genome has revealed the positions of approximately 20,000 genes. In addition, nearly 50% of the human genome is comprised of repetitive sequences previously thought of as junk DNA. Numerous studies are now finding that this DNA actually has a variety of important functions, particularly in the control of gene activity. This project will examine the relationships between gene expression and nearby repetitive sequences during the innate immune response in humans.